| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 51 | 2024 | 214 | 12.790 |
Why?
|
| Probiotics | 18 | 2024 | 89 | 4.500 |
Why?
|
| Glutens | 21 | 2024 | 84 | 4.380 |
Why?
|
| Diet, Gluten-Free | 17 | 2022 | 58 | 2.870 |
Why?
|
| Diarrhea | 9 | 2020 | 178 | 2.400 |
Why?
|
| Gastrointestinal Diseases | 8 | 2017 | 151 | 1.520 |
Why?
|
| Food Hypersensitivity | 5 | 2018 | 71 | 1.460 |
Why?
|
| Transglutaminases | 9 | 2023 | 40 | 1.430 |
Why?
|
| Child | 35 | 2023 | 7240 | 1.380 |
Why?
|
| Immunoglobulin A | 5 | 2023 | 83 | 1.370 |
Why?
|
| Irritable Bowel Syndrome | 5 | 2020 | 46 | 1.180 |
Why?
|
| Autoantibodies | 8 | 2019 | 270 | 1.150 |
Why?
|
| Triticum | 3 | 2017 | 32 | 1.090 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 565 | 1.080 |
Why?
|
| Child, Preschool | 17 | 2020 | 3771 | 0.880 |
Why?
|
| Dysbiosis | 1 | 2024 | 81 | 0.860 |
Why?
|
| Colitis, Ulcerative | 3 | 2024 | 760 | 0.850 |
Why?
|
| Humans | 81 | 2024 | 89961 | 0.830 |
Why?
|
| Gastroenteritis | 2 | 2015 | 26 | 0.810 |
Why?
|
| HLA-DQ Antigens | 4 | 2019 | 51 | 0.790 |
Why?
|
| Duodenum | 5 | 2022 | 105 | 0.790 |
Why?
|
| Gastroenterology | 6 | 2019 | 147 | 0.770 |
Why?
|
| Abdominal Pain | 3 | 2020 | 142 | 0.740 |
Why?
|
| Infant | 17 | 2020 | 3188 | 0.730 |
Why?
|
| Oryza | 2 | 2018 | 42 | 0.730 |
Why?
|
| Constipation | 2 | 2020 | 64 | 0.720 |
Why?
|
| Practice Guidelines as Topic | 7 | 2019 | 1055 | 0.710 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 520 | 0.710 |
Why?
|
| Biopsy | 9 | 2023 | 1184 | 0.690 |
Why?
|
| Adolescent | 20 | 2020 | 9340 | 0.690 |
Why?
|
| Blood Chemical Analysis | 1 | 2019 | 41 | 0.660 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 374 | 0.660 |
Why?
|
| Crohn Disease | 6 | 2024 | 764 | 0.660 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2019 | 18 | 0.650 |
Why?
|
| Weaning | 4 | 2016 | 25 | 0.650 |
Why?
|
| Automation | 1 | 2019 | 112 | 0.640 |
Why?
|
| Gliadin | 3 | 2016 | 17 | 0.620 |
Why?
|
| Wheat Hypersensitivity | 2 | 2017 | 4 | 0.610 |
Why?
|
| Intestinal Mucosa | 11 | 2024 | 806 | 0.610 |
Why?
|
| Inflammatory Bowel Diseases | 5 | 2024 | 594 | 0.610 |
Why?
|
| Egg Yolk | 1 | 2017 | 4 | 0.580 |
Why?
|
| Enterocolitis, Necrotizing | 4 | 2015 | 80 | 0.570 |
Why?
|
| Diagnosis, Differential | 4 | 2020 | 1606 | 0.570 |
Why?
|
| Beer | 1 | 2016 | 1 | 0.560 |
Why?
|
| Direct Service Costs | 1 | 2016 | 2 | 0.550 |
Why?
|
| Infant Nutritional Physiological Phenomena | 2 | 2007 | 19 | 0.540 |
Why?
|
| Health Status | 2 | 2011 | 371 | 0.510 |
Why?
|
| Lactobacillus | 5 | 2011 | 21 | 0.510 |
Why?
|
| Treatment Outcome | 14 | 2024 | 8273 | 0.500 |
Why?
|
| Breast Feeding | 5 | 2016 | 105 | 0.490 |
Why?
|
| Diet, Mediterranean | 1 | 2015 | 5 | 0.490 |
Why?
|
| Ambulatory Care | 1 | 2016 | 186 | 0.480 |
Why?
|
| Immunoglobulin G | 1 | 2016 | 469 | 0.470 |
Why?
|
| Autoimmunity | 3 | 2010 | 169 | 0.420 |
Why?
|
| Infant, Newborn | 8 | 2020 | 2497 | 0.410 |
Why?
|
| Diet | 3 | 2017 | 444 | 0.410 |
Why?
|
| GTP-Binding Proteins | 4 | 2020 | 145 | 0.400 |
Why?
|
| Hospitalization | 2 | 2016 | 888 | 0.400 |
Why?
|
| Health Care Surveys | 1 | 2012 | 281 | 0.370 |
Why?
|
| Food | 1 | 2011 | 89 | 0.370 |
Why?
|
| Fetal Development | 1 | 2011 | 31 | 0.360 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2015 | 319 | 0.360 |
Why?
|
| Guideline Adherence | 1 | 2012 | 234 | 0.340 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2015 | 841 | 0.340 |
Why?
|
| Remission Induction | 4 | 2018 | 741 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2019 | 2360 | 0.330 |
Why?
|
| Intestine, Small | 4 | 2016 | 299 | 0.330 |
Why?
|
| Male | 24 | 2022 | 42674 | 0.320 |
Why?
|
| Child Development | 1 | 2011 | 167 | 0.320 |
Why?
|
| Adult | 16 | 2019 | 26816 | 0.310 |
Why?
|
| Child Nutrition Sciences | 2 | 2018 | 2 | 0.310 |
Why?
|
| Rotavirus Infections | 1 | 2008 | 12 | 0.310 |
Why?
|
| Colon | 3 | 2011 | 521 | 0.300 |
Why?
|
| Female | 22 | 2020 | 46587 | 0.290 |
Why?
|
| Immunologic Factors | 1 | 2008 | 171 | 0.280 |
Why?
|
| Inflammation | 3 | 2019 | 981 | 0.280 |
Why?
|
| Societies, Medical | 4 | 2018 | 584 | 0.280 |
Why?
|
| Cross Infection | 4 | 2011 | 151 | 0.270 |
Why?
|
| Milk, Human | 1 | 2007 | 46 | 0.270 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2018 | 163 | 0.270 |
Why?
|
| Bifidobacterium | 3 | 2011 | 17 | 0.270 |
Why?
|
| Colonic Diseases | 1 | 2016 | 61 | 0.260 |
Why?
|
| Anti-Bacterial Agents | 4 | 2015 | 798 | 0.260 |
Why?
|
| Retrospective Studies | 8 | 2020 | 9210 | 0.260 |
Why?
|
| Risk Factors | 10 | 2018 | 5558 | 0.260 |
Why?
|
| Infant Formula | 1 | 2005 | 17 | 0.260 |
Why?
|
| Environmental Exposure | 1 | 2008 | 334 | 0.260 |
Why?
|
| Health Care Reform | 1 | 2016 | 85 | 0.250 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 107 | 0.250 |
Why?
|
| Colectomy | 1 | 2016 | 175 | 0.250 |
Why?
|
| Physicians | 1 | 2012 | 692 | 0.230 |
Why?
|
| Antibodies | 2 | 2019 | 353 | 0.230 |
Why?
|
| Double-Blind Method | 4 | 2018 | 1714 | 0.230 |
Why?
|
| Interleukin-15 | 3 | 2015 | 73 | 0.230 |
Why?
|
| Women's Health | 1 | 2005 | 103 | 0.230 |
Why?
|
| Saccharomyces | 2 | 2015 | 22 | 0.230 |
Why?
|
| Cross-Over Studies | 2 | 2018 | 387 | 0.220 |
Why?
|
| Pediatrics | 2 | 2018 | 360 | 0.220 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 244 | 0.220 |
Why?
|
| Evidence-Based Medicine | 4 | 2016 | 435 | 0.210 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 2 | 2015 | 32 | 0.210 |
Why?
|
| Acute Disease | 4 | 2008 | 846 | 0.210 |
Why?
|
| Predictive Value of Tests | 4 | 2019 | 1732 | 0.200 |
Why?
|
| Disulfides | 1 | 2022 | 65 | 0.200 |
Why?
|
| Genetic Testing | 2 | 2019 | 543 | 0.200 |
Why?
|
| Animals | 10 | 2024 | 27528 | 0.200 |
Why?
|
| Thiorphan | 1 | 2002 | 5 | 0.200 |
Why?
|
| Comorbidity | 2 | 2016 | 953 | 0.190 |
Why?
|
| Meta-Analysis as Topic | 2 | 2015 | 81 | 0.190 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 1862 | 0.190 |
Why?
|
| Cohort Studies | 2 | 2019 | 2886 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 608 | 0.190 |
Why?
|
| Insurance, Health | 2 | 2016 | 164 | 0.180 |
Why?
|
| Intestines | 3 | 2019 | 416 | 0.180 |
Why?
|
| Environment | 2 | 2014 | 225 | 0.180 |
Why?
|
| Aging | 1 | 2005 | 727 | 0.180 |
Why?
|
| Time Factors | 5 | 2018 | 5358 | 0.180 |
Why?
|
| Child Day Care Centers | 2 | 2011 | 6 | 0.180 |
Why?
|
| Health Care Costs | 2 | 2016 | 236 | 0.180 |
Why?
|
| Laxatives | 1 | 2020 | 13 | 0.170 |
Why?
|
| Quality of Life | 3 | 2016 | 1682 | 0.170 |
Why?
|
| Antigens | 2 | 2019 | 229 | 0.170 |
Why?
|
| Th1 Cells | 2 | 2017 | 166 | 0.160 |
Why?
|
| Risk Assessment | 4 | 2016 | 2327 | 0.160 |
Why?
|
| Body Mass Index | 2 | 2020 | 776 | 0.160 |
Why?
|
| Starch | 1 | 2018 | 8 | 0.160 |
Why?
|
| Age Factors | 2 | 2018 | 1880 | 0.150 |
Why?
|
| Pathology, Clinical | 1 | 2018 | 34 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 105 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 360 | 0.150 |
Why?
|
| Prevalence | 3 | 2020 | 1250 | 0.150 |
Why?
|
| Prognosis | 3 | 2016 | 3798 | 0.140 |
Why?
|
| Reoviridae Infections | 1 | 2017 | 7 | 0.140 |
Why?
|
| Middle Aged | 7 | 2019 | 26146 | 0.140 |
Why?
|
| Europe | 3 | 2018 | 324 | 0.140 |
Why?
|
| Young Adult | 3 | 2019 | 6409 | 0.140 |
Why?
|
| Interprofessional Relations | 1 | 2018 | 121 | 0.140 |
Why?
|
| Case-Control Studies | 3 | 2016 | 1866 | 0.140 |
Why?
|
| Feeding Behavior | 2 | 2020 | 328 | 0.140 |
Why?
|
| Flour | 1 | 2016 | 2 | 0.140 |
Why?
|
| Sorghum | 1 | 2016 | 4 | 0.140 |
Why?
|
| Hordeum | 1 | 2016 | 10 | 0.140 |
Why?
|
| Internationality | 1 | 2016 | 70 | 0.140 |
Why?
|
| Sex Distribution | 1 | 2016 | 171 | 0.130 |
Why?
|
| Age Distribution | 1 | 2016 | 199 | 0.130 |
Why?
|
| Leadership | 1 | 2018 | 141 | 0.130 |
Why?
|
| Antibody Formation | 1 | 2016 | 171 | 0.130 |
Why?
|
| Allergens | 1 | 2017 | 183 | 0.130 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 153 | 0.130 |
Why?
|
| Peptides | 1 | 2019 | 649 | 0.130 |
Why?
|
| Leukotrienes | 1 | 2015 | 20 | 0.130 |
Why?
|
| Infant, Premature | 2 | 2015 | 299 | 0.130 |
Why?
|
| Immunoglobulin E | 2 | 2017 | 145 | 0.130 |
Why?
|
| Reference Values | 1 | 2016 | 662 | 0.130 |
Why?
|
| Attitude | 1 | 2016 | 130 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2019 | 866 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 1730 | 0.120 |
Why?
|
| Adolescent Health | 1 | 2014 | 5 | 0.120 |
Why?
|
| Cysteine | 1 | 2015 | 137 | 0.120 |
Why?
|
| Cell Communication | 1 | 2015 | 200 | 0.120 |
Why?
|
| Dietary Supplements | 2 | 2016 | 124 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 167 | 0.110 |
Why?
|
| Mentors | 1 | 2014 | 90 | 0.110 |
Why?
|
| United States | 5 | 2016 | 7108 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2015 | 232 | 0.110 |
Why?
|
| Global Health | 1 | 2015 | 193 | 0.110 |
Why?
|
| Epithelial Cells | 2 | 2015 | 689 | 0.110 |
Why?
|
| Feces | 2 | 2011 | 333 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2014 | 188 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2012 | 69 | 0.100 |
Why?
|
| History, 21st Century | 3 | 2018 | 184 | 0.100 |
Why?
|
| Fluid Therapy | 2 | 2002 | 51 | 0.100 |
Why?
|
| History, 20th Century | 3 | 2018 | 314 | 0.090 |
Why?
|
| Community-Acquired Infections | 1 | 2011 | 65 | 0.090 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 2 | 0.090 |
Why?
|
| Mass Screening | 2 | 2014 | 647 | 0.090 |
Why?
|
| Surveys and Questionnaires | 3 | 2019 | 2655 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2019 | 4329 | 0.090 |
Why?
|
| Tight Junctions | 1 | 2011 | 150 | 0.090 |
Why?
|
| Incidence | 1 | 2015 | 1603 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 77 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2010 | 125 | 0.080 |
Why?
|
| Disease Management | 1 | 2012 | 327 | 0.080 |
Why?
|
| Phospholipases A2, Cytosolic | 1 | 2009 | 4 | 0.080 |
Why?
|
| Family | 1 | 2010 | 324 | 0.080 |
Why?
|
| Diet Therapy | 1 | 2008 | 20 | 0.080 |
Why?
|
| Italy | 2 | 2020 | 108 | 0.070 |
Why?
|
| Biological Products | 1 | 2010 | 161 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 2393 | 0.070 |
Why?
|
| Rats, Wistar | 2 | 2022 | 303 | 0.070 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 166 | 0.070 |
Why?
|
| Infant Food | 1 | 2007 | 11 | 0.070 |
Why?
|
| Massachusetts | 1 | 2016 | 33 | 0.070 |
Why?
|
| Immune System | 1 | 2008 | 97 | 0.070 |
Why?
|
| Dysentery | 1 | 2006 | 3 | 0.070 |
Why?
|
| Helicobacter Infections | 1 | 2006 | 37 | 0.060 |
Why?
|
| Nutritional Requirements | 1 | 2005 | 17 | 0.060 |
Why?
|
| Helicobacter pylori | 1 | 2006 | 37 | 0.060 |
Why?
|
| Consumer Product Safety | 1 | 2005 | 11 | 0.060 |
Why?
|
| Pyloric Stenosis | 1 | 2005 | 8 | 0.060 |
Why?
|
| Serologic Tests | 2 | 2005 | 43 | 0.060 |
Why?
|
| Professional-Patient Relations | 1 | 2005 | 54 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2010 | 948 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 276 | 0.060 |
Why?
|
| Biomarkers | 2 | 2022 | 1778 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 596 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 2005 | 200 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2015 | 3404 | 0.050 |
Why?
|
| Pregnancy | 1 | 2011 | 3046 | 0.050 |
Why?
|
| School Nursing | 1 | 2003 | 3 | 0.050 |
Why?
|
| Obesity | 2 | 2020 | 972 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2019 | 395 | 0.050 |
Why?
|
| Diarrhea, Infantile | 1 | 2002 | 2 | 0.050 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2002 | 12 | 0.050 |
Why?
|
| Sulfhydryl Compounds | 1 | 2022 | 71 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 168 | 0.050 |
Why?
|
| Antidiarrheals | 1 | 2002 | 14 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2008 | 698 | 0.050 |
Why?
|
| Developed Countries | 1 | 2002 | 25 | 0.050 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2001 | 1 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2002 | 72 | 0.050 |
Why?
|
| Rats | 2 | 2022 | 4048 | 0.050 |
Why?
|
| Aged | 3 | 2017 | 19254 | 0.050 |
Why?
|
| Developing Countries | 1 | 2002 | 80 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2002 | 82 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 3678 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2019 | 958 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2020 | 81 | 0.040 |
Why?
|
| Thinness | 1 | 2020 | 46 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 418 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1670 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2015 | 726 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2002 | 872 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1533 | 0.040 |
Why?
|
| Starvation | 1 | 1999 | 23 | 0.040 |
Why?
|
| Bacterial Adhesion | 1 | 1999 | 84 | 0.040 |
Why?
|
| Cecum | 1 | 1999 | 73 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2022 | 458 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2019 | 125 | 0.040 |
Why?
|
| Overweight | 1 | 2020 | 119 | 0.040 |
Why?
|
| Butyrophilins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2019 | 16 | 0.040 |
Why?
|
| Body Weight | 1 | 2020 | 453 | 0.040 |
Why?
|
| Anniversaries and Special Events | 1 | 2018 | 15 | 0.040 |
Why?
|
| North America | 1 | 2018 | 188 | 0.040 |
Why?
|
| Reoviridae | 1 | 2017 | 6 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2018 | 115 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 20 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 646 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2017 | 115 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2016 | 152 | 0.030 |
Why?
|
| Atrophy | 1 | 2016 | 124 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2018 | 230 | 0.030 |
Why?
|
| Interferon Type I | 1 | 2017 | 186 | 0.030 |
Why?
|
| Child Health Services | 1 | 2016 | 49 | 0.030 |
Why?
|
| Syndrome | 1 | 2017 | 450 | 0.030 |
Why?
|
| Receptors, Leukotriene | 1 | 2015 | 10 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2015 | 22 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2015 | 50 | 0.030 |
Why?
|
| Chicago | 1 | 2020 | 1434 | 0.030 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2009 | 1130 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 123 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2017 | 341 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 115 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 183 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2014 | 126 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1576 | 0.030 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 68 | 0.030 |
Why?
|
| Algorithms | 1 | 2001 | 1913 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 460 | 0.030 |
Why?
|
| Recurrence | 2 | 2005 | 1145 | 0.020 |
Why?
|
| Guanidines | 1 | 2011 | 31 | 0.020 |
Why?
|
| Enema | 1 | 2011 | 39 | 0.020 |
Why?
|
| Defecation | 1 | 2011 | 23 | 0.020 |
Why?
|
| Occludin | 1 | 2011 | 66 | 0.020 |
Why?
|
| Permeability | 1 | 2011 | 138 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2011 | 70 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 250 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 401 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2010 | 46 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2011 | 261 | 0.020 |
Why?
|
| Pain Management | 1 | 2011 | 144 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2011 | 280 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2887 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 3252 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1469 | 0.020 |
Why?
|
| Cell Degranulation | 1 | 2009 | 14 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2009 | 63 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2009 | 81 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 112 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 123 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 215 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 2456 | 0.020 |
Why?
|
| Pouchitis | 1 | 2008 | 54 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 696 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 11851 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2006 | 18 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6783 | 0.020 |
Why?
|
| Vaginosis, Bacterial | 1 | 2006 | 8 | 0.020 |
Why?
|
| Bacteria | 1 | 2010 | 486 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 136 | 0.020 |
Why?
|
| Placebos | 1 | 2005 | 211 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 2006 | 150 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1227 | 0.020 |
Why?
|
| Lymphoma | 1 | 2006 | 266 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 449 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 383 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 2329 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2003 | 227 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3024 | 0.010 |
Why?
|
| Haplotypes | 1 | 2003 | 637 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1452 | 0.010 |
Why?
|
| Ion Transport | 1 | 1999 | 85 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 716 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 1214 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1999 | 403 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1999 | 172 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1983 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1999 | 1091 | 0.010 |
Why?
|